| 
Citations
 | 
   web
Brown, D. V., Filiz, G., Daniel, P. M., Hollande, F., Dworkin, S., Amiridis, S., et al. (2017). Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. PLoS One, 12(2), e0172791.
toggle visibility
Ludwig, K., & Kornblum, H. I. (2017). Molecular markers in glioma. J Neurooncol, .
toggle visibility
Alshehri, M. M., Robbins, S. M., & Senger, D. L. (2017). The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75NTR/CD271). Vitam Horm, 104, 367–404.
toggle visibility
D'Alessandris, Q. G., Biffoni, M., Martini, M., Runci, D., Buccarelli, M., Cenci, T., et al. (2017). The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response. Neuro Oncol, 19(8), 1097–1108.
toggle visibility
Howard, C. M., Valluri, J., Alberico, A., Julien, T., Mazagri, R., Marsh, R., et al. (2017). Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients. Transl Oncol, 10(2), 241–254.
toggle visibility